AtriCure (ATRC) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $51.16 +4.58%
Revenue Growth %: +12.6%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: +12.6%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $46.1 million versus the consensus estimate of $45.36 million.
2018 Financial Guidance
Management projects 2018 revenue of approximately $190 million to $196 million. Adjusted EBITDA, a non-GAAP measure, is projected to be positive for 2018.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AtriCure Inc. (ATRC) PT Raised to $64 at Needham
- TSX miners rally as precious metals stocks dominate top gainers
- Yatsen Holding (YSG) Reports Q2 Loss of $0.16
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
